Identifying high-risk areas of bacillary dysentery and associated meteorological factors in Wuhan, China

by Li, Zhenjun, Wang, Ligui, Sun, Weige, Hou, Xuexin, Yang, Haiyan, Sun, Lina, Xu, Shuai, Sun, Qiangzheng, Zhang, Jingshan, Song, Hongbin, Lin, Hualiang
Published 2013

Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed...

by Dimopoulos, Meletios A., Palumbo, Antonio, Hajek, Roman, Kropff, Martin, Petrucci, Maria Teresa, Lewis, Philip, Millar, Stefanie, Zhang, Jingshan, Mei, Jay, Delforge, Michel
Published 2014

A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial

by Hou, Jian, Du, Xin, Jin, Jie, Cai, Zhen, Chen, Fangping, Zhou, Dao-bin, Yu, Li, Ke, Xiaoyan, Li, Xiao, Wu, Depei, Meng, Fanyi, Ai, Huisheng, Zhang, Jingshan, Wortman-Vayn, Honeylet, Chen, Nianhang, Mei, Jay, Wang, Jianmin
Published 2013

Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program

by Du, Xin, Jin, Jie, Cai, Zhen, Chen, Fangping, Zhou, Dao-bin, Yu, Li, Ke, Xiaoyan, Li, Xiao, Wu, Depei, Meng, Fanyi, DeMarco, Dena, Zhang, Jingshan, Mei, Jay, Hou, Jian
Published 2016